Clough Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Clough Capital Partners's AMGN Position: Q1 2024 in Review
Clough Capital Partners sold out of Amgen (AMGN) in Q1 2024, closing a stake of 3,762 shares — an estimated $1.08M sold.
Clough Capital Partners first reported a position in AMGN in Q1 2018 and held it in 17 quarters. The position peaked at $29.3M in Q3 2020. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Clough Capital Partners reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
- Clough Capital Partners sold 3,762 Amgen shares in Q1 2024, an estimated $1.08M.
- Clough Capital Partners first reported a position in Amgen in Q1 2018 and held it in 17 quarters.
- Clough Capital Partners's Amgen position peaked at $29.3M in Q3 2020.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Clough Capital Partners's 13F filing for Q1 2024, filed 15 May 2024.